icon-data-alerts Sign up for FREE: Data Alerts | e-Newsflash (see Archives)
HIV/AIDS Data Hub for the Asia-Pacific Region
 
You are here: Reference Library HIV Treatment PMTCT Treatment Programmatic Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. WHO (2012)
Wednesday, 27 June 2012 10:21

Programmatic Update: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. WHO (2012)

Use of_ARV__for_Pregnant_Women

Recent developments suggest that substantial clinical and programmatic advantages can come from adopting a single, universal regimen both to treat HIV-infected pregnant women and to prevent mother-to-child transmission of HIV. This streamlining should maximize PMTCT programme performance through better alignment and linkages with antiretroviral therapy (ART) programmes at every level of service delivery. One of WHO’s two currently recommended PMTCT antiretroviral (ARV) programme options, Option B, takes this unified approach.

Download this publication

 

 
Read 3528 times
Published in PMTCT Treatment
Tagged under

Related items

More in this category: « Barriers to Access Prevention of Mother-to-Child Transmission for HIV Positive Women in a Well-Resourced Setting in Vietnam. Nguyen TA, Oosterhoff P, Ngoc YP, et al (2008) Rapid Advice: Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. WHO (2009) »
back to top